ReviewMedical oncology (Northwood, London, England)2026
MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma.
Review in Medical oncology (Northwood, London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Oral Squamous Cell Carcinoma (OSCC) is the most aggressive oral cancer type, with minimal survival rates resulting from metastases and disease recurrence. Early detection and innovative treatment approaches are required to limit metastases and improve survival rates. Dysregulated signaling affects a behavioral change in OSCC tumors, with alterations observed in tumor cell growth, proliferation, resistance to death etc. Aberrant signaling also plays an essential role in OSCC metabolic conditioning, helping tumors adapt to diverse host tissue microenvironments. Multiple miRNAs regulate signaling cascades in OSCC by controlling the expression of receptors, effectors and regulator genes. Therefore, the expression of specific miRNA in OSCC tumors can serve as diagnostic indictors as well as critical predictors for disease progression. In this review, we catalog miRNAs in OSCC with specific emphasis on their role in modulating signaling pathways associated with metabolic reprogramming.
Indexed as
Identifiers
41652270What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.